US 11453891
Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9
granted A61KA61K48/00A61P
Quick answer
US patent 11453891 (Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9) held by The Regents of the University of California expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K48/00, A61P, A61P21/00